Introduction
============

Many of the hurdles to combating antibiotic-resistant infections in the clinic are well understood and, as such, have been used to inform existing antimicrobial resistance (AMR) Action Plans ([@B68]; [@B59]; [@B238]). It is argued, that our inability to satisfactorily answer fundamental questions about AMR in the environment is responsible for the lack of any significant environmental focus in existing AMR Action Plans and the O'Neill AMR Reviews ([@B164]). It is further argued that without inclusion or consideration of all the drivers and pathways of AMR into the environment, AMR Action Plans are incomplete and at risk of not achieving the desired goals of ensuring and improving the efficacy of existing and future antibiotics.

In this review, we aim to present the AMR challenge through the lens of an environmental regulator, using the Environment Agency (England's regulator) as an example from which parallels can be drawn globally. We argue that there is an evidence gap that hinders the ability of policymakers and environmental regulators from delivering environmental protection from AMR. The following five questions exemplify the approach taken by an environmental regulator when tackling the AMR challenge. The inability to answer these questions, in this point in time, highlights some of the evidence gaps that need to be prioritized to facilitate a holistic, evidence-based AMR Action Plan:

1.  What are the benefits of controlling AMR in the environment over and above mitigating the potential transmission of resistance to humans?

2.  What is the relative contribution from the release of antibiotics, metals, biocides, and antibiotic resistance genes (ARGs) to the emergence, maintenance and spread of AMR in the environment?

3.  How well do current technologies and approaches limit AMR in the environment?

4.  If reducing AMR needs to be reflected within our regulatory framework, how could this best be tackled?

5.  Is there evidence to suggest that expansion of existing regulation/control measures for pollutants to AMR will translate into a decline in AMR in the environment?

Here, we review the pertinent issues that lie at the root of the aforementioned questions, such as: What are the drivers and pathways of AMR? And, How do these relate to the normal work, powers and duties of environmental regulators? The discussion is then turned to: What are the knowledge gaps that hinder the delivery of environmental protection from AMR? Finally, we offer several thought experiments for how different mitigation strategies might proceed in the light of a holistic understanding of AMR drivers and pathways. It is the intention that this review would be a catalyst for future discussions among scientists, policymakers, clinicians, veterinarians, and regulators. It is also our expectation that this review will stimulate a more systematic review and meta-analysis of the literature to further examine and critique the evidence base and the changing state of our knowledge gaps.

Background of Global, Regional and National AMR Action Plans
============================================================

The World Health Organisation (WHO) and its Global Action Plan broadly outlines five strategic objectives to tackle AMR: (1) to improve awareness and understanding of AMR; (2) to strengthen knowledge through surveillance and research; (3) to reduce the incidence of infection; (4) to optimize the use of antimicrobial agents; and (5) to ensure sustainable investment in countering AMR ([@B238]). The WHO highlights the role of the environment in Objective 4 of the Action Plan: "\[To\] Develop standards and guidance\...for the presence of antimicrobial agents and their residues in the environment, especially in water, wastewater and food (including aquatic and terrestrial animal feed)." A similar action plan was published by the [@B68]. However, the only mention of the role of the environment was in 'Action Number 8,' which details the need to "Initiate cooperation on [reduction of the environmental pollution]{.ul} by antimicrobial medicines particularly from [production facilities]{.ul}." The highlighting of pharmaceutical manufacturing is echoed in the O'Neill AMR Review, discussed below. Although rivers that receive eﬄuent from drug manufacturers have been shown to be a very important local issue with global implications ([@B135]), it will be shown in subsequent sections to be only one pathway among several (see **Figure [1](#F1){ref-type="fig"}**). Moreover, it will be shown that antibiotics are only one of the many drivers of AMR in the environment.

![**Schematic of the hot-spots and drivers of antimicrobial resistance (AMR).** The environmental compartments that are currently monitored or regulated by the Environment Agency (EA; England) are denoted by an asterisk in red. WFD, Water Framework Directive.](fmicb-07-01728-g001){#F1}

The final Review on Antimicrobial Resistance entitled "Tackling drug-resistant infections globally: Final report and recommendations" ([@B164]) highlighted the need to reduce environmental pollution of antibiotics in much the same way as have done the WHO and EC AMR Action Plans. In brief, it highlights three pathways: (1) animal waste, (2) human waste, and (3) manufacturing waste. In every case the focus was on antibiotics, without any mention of other resistance-driving chemicals. It also prioritizes two pathways: hospital eﬄuent and pharmaceutical manufacturing plants. It is difficult to argue against improving these two pathways, as they are both highly relevant at a spatially resolved scale of analysis, however, these inputs are relatively small in number as compared to the overwhelming input of all resistance-driving chemicals from all the sources (see **Figure [1](#F1){ref-type="fig"}**). Moreover, it is unproven that WWTPs receiving eﬄuent from hospitals discharge significantly more resistance-driving chemicals into the environment, with measurably greater impact, than other similarly sized WWTPs. Although hospitals are an easy target and in many ways a tractable target, it does not necessarily make them the highest priority for reducing the prevalence of AMR in the environment. It is argued that the vision for these action plans is not sufficiently holistic to safeguard our natural environment. To appreciate these critiques, one must first understand what drives AMR in the environment.

Fundamental Questions of AMR in the Environment: What are the Drivers and Pathways of AMR in the Environment?
=============================================================================================================

Broadly speaking, antibiotic use in humans and animals carries an inherent risk of selecting for ARGs. These ARGs are often, if not always, found in bacteria with other genes promoting resistance to other potentially harmful chemicals ([@B5]; [@B137]; [@B65]; [@B202]). It is most helpful to see these genes as 'resistance genes' (not ARGs), because antibiotics are not the only chemicals that select for resistance genes. It is an unfortunate historical convention to label all these genes antimicrobial resistance genes (ARGs), when in fact they can potentially confer resistance to many more chemicals.

A review of the literature highlights three well-characterized classes of resistance-driving chemicals: (1) antimicrobials, of which there are four subclasses, antibiotics, antifungals, antivirals, and antiparasitics; (2) heavy metals; (3) biocides (i.e., disinfectants and surfactants). However, many other chemicals, natural \[e.g., plant-derived ([@B81])\], and xenobiotic \[e.g., solvents such as octanol, hexane and toluene ([@B179]; [@B73])\], are also known to select for resistance genes. The prevalence of resistance genes in the environment are the result of a complex combination of factors, that reflect a dynamic balance of fitness costs and benefits: costs of carrying the ARG in the context of the host genome and environment ([@B147]; [@B184]); relative to the severity and frequency of hazard ([@B96], [@B95]); relative to some physical environmental factors, such as temperature ([@B89]) and microbial ecology ([@B7]), among others.

Co-selection of genes that confer resistance to chemical hazards \[solvents ([@B73]), biocides ([@B167]; [@B224]; [@B232]), antibiotics ([@B137]; [@B21]), and metals ([@B170]; [@B167])\] is a potentially ecologically and clinically important phenomenon. Co-selection is achieved in two ways: (1) co-resistance, whereby selection for one gene fosters the maintenance of another resistance gene, one that does not necessarily offer a selective advantage to the chemical in question ([@B117]); and (2) cross-resistance, whereby one resistance gene can offer protection from multiple toxic chemicals ([@B52]). Co-resistance is analogous to bringing a toolbox to a worksite; one might only need one or two tools from the toolbox at any one time, but there are many tools 'fortuitously' available for use should the need arise. The genomic architecture (e.g., ARGs found within: plasmids, transposons, and integrons) is the toolbox and the resistance genes that are co-located in the genome are the tools. Cross-resistance is analogous to having a tool that is capable of multiple functions, such as a claw hammer, which can hammer in as well as extract a nail, thereby offering multiple functions from the same tool. Eﬄux pumps can often provide cross-resistance to multiple chemicals.

The literature describes three major pathways for resistance-driving chemicals into the environment (see **Figure [1](#F1){ref-type="fig"}**):

1.  Municipal and industrial wastewater;

2.  Land spreading of animal manure and sewage sludge; and

3.  Aquaculture.

Additional pathways will be discussed (e.g., aerosols and mining), however, they were not included in **Figure [1](#F1){ref-type="fig"}** as it was felt that the evidence base for their importance needs further strengthening.

Drivers of Resistance: Antibiotics
==================================

Scale of Human Antibiotic Use
-----------------------------

In 2013, the total measured consumption of antibiotics in England was 27.4 DDD per 1000 inhabitants per day \[general practice 79%, hospital 15% and other community consumption (predominantly dentists) 6%\], in line with the median across Europe in 2011 of 21.3 median DDD per 1000 inhabitants per day ([@B176]), where the DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. A total of 66 different antibiotics were prescribed, with the top 15 antibiotics in general practice and hospitals accounting for 98 and 88% of consumption, respectively ([@B176]).

In 2010, India was the largest consumer of antibiotics when assessing total tonnage, however, their per capita usage (7.5 units per capita), was low by comparison to Australia and New Zealand which recorded among the highest usage rates of 87 and 70 units per capita, respectively ([@B218]). An antibiotic unit was defined in this study as the number of doses (i.e., pill, capsule, or ampoule) sold ([@B218]). China was the second largest consumer of antibiotics, globally when assessing total tonnage, but similar to India, recorded relatively low antibiotic usage per capita (7.5 units).

Heterogeneity in antibiotic use is reproduced at seemingly every geographical scale. For example, nested within the larger global differences are differences between countries within smaller regions, e.g., Europe, where nearly 300% more antibiotics were used per capita in Turkey than Armenia ([@B220]). Within Europe, the highest defined daily dose (DDD) of antibiotics (outpatient) per capita is France (32 DDD) and Greece (30 DDD), with the UK (15 DDD) exceeding that of the lowest use European country, The Netherlands, by 33% ([@B91]). Differences between countries is often attributed to the ease at which one can self-medicate, with eastern and southern European countries (e.g., Bulgaria, Cyprus, Greece, Lithuania, Romania, and Spain), demonstrating greater access to antibiotics without a prescription, thereby increasing use and misuse ([@B186]). In general, per capita antibiotic use across Europe is lowest in northern regions, moderate in eastern regions and highest in southern regions ([@B91]).

In addition, to there being large differences between countries within regions, there are significant differences in antibiotic use within countries. The highest combined general practice and hospital antibiotic consumption was in Merseyside, with similar levels reported in Southern Europe with 30.4 DDD per 1,000 inhabitants per day, over 30% higher than Thames Valley with the lowest consumption, (22.8 DDD per 1,000 inhabitants per day) ([@B176]). Durham, an area in the northeast of England reported 40% more antibiotic prescriptions in general practice than in London (southeast England) ([@B176]). The ESPAUR Report 2014 notes that areas within the UK that report high antibiotic prescription rates also reported higher antibiotic resistance rates; a finding the authors acknowledged necessitates further examination. It remains unexplored as to whether these regional variations in antibiotic prescriptions translate into differences in risk to antibiotic resistance selection and maintenance in the environment. The evidence of heterogeneous antibiotic use across large and small scales likely has multiple causes and as such, AMR Action Plans need to be sufficiently holistic to address the diversity of aetiologies.

Scale of Animal Antibiotic Use
------------------------------

According to The State of the World's Antibiotics 2015, two-thirds of all of the antibiotics produced globally each year (65,000 tons of 100,000 tons) are used in animal husbandry ([@B88]). The variability between countries in veterinary antimicrobial use in food-producing animals just within the high income countries can be significant. Sales of veterinary antimicrobial agents among the 26 EU countries in 2013 expressed as mg of antibiotic per population correction unit (PCU) places Norway as having the lowest mg/PCU at: 3.7 mg/PCU, with the UK at 62.1 mg/PCU. PCU is a standard unit of measure that takes into account the number of animals in a country and their average weight at the point they are most likely to be treated, providing an estimate of total kg of food producing animal in a country. At the upper end of veterinary antimicrobial use in the EU, was Italy (301.6 mg/PCU), Spain (317.1 mg/PCU), and Cyprus (425.8 mg/PCU) ([@B71]). The majority of these sales are for tetracycline and penicillin antibiotic classes, composing between 6--56 and 11--61% of the total antibiotics sold in each country for food-producing animals, respectively ([@B71]). In combination with sulfonamides, these three classes of antibiotic account for 71% of the total sales in these 26 European Union (EU)/European Economic Area (EEA) countries in 2013.

In 2013, the total antibiotic sales for therapeutic use in animals, was 420 tons, approximately 44% of the total antibiotic usage in the UK ([@B177]). The number of livestock in the UK in 2013 was: cattle (9.8 m), pigs (4.9 m), sheep (32.8 m), chicken (162.6 m) ([@B222]). The milligrams of active ingredient of critically important antibiotics (CIA) sold for food producing animals per PCU for 2013 was: cattle (8 mg/pcu), pigs and poultry (172 mg/pcu) ([@B222]). Tetracyclines were the most frequently used antibiotics in animals (43.5%), followed by penicillins (21.7%), mirroring the use patterns in humans where it was reversed, penicillins (64%) followed by tetracyclines (10%) ([@B177]). The estimate that roughly 44% of the antibiotics used in the UK are for veterinary use, is much lower than estimates for other countries, such as the U.S., where \>70% of antibiotics are estimated to be used in livestock ([@B163]).

Antibiotics are important for maintaining animal health and welfare. Antibiotics are often dispensed to treat or prevent infections in herds/flocks ([@B88]). Antibiotics are often added to the animal's water or food as a pragmatic solution to the fact that they are reared in groups/flocks making it difficult to isolate and treat only the infected. In addition, the effort to isolate animals could be stressful to the animal and sometimes dangerous to the veterinarian who administers the antibiotic.

The use of antibiotics for growth promotion has been banned in Europe and is in decline in North America. Major food suppliers such as Tyson ([@B211]), McDonalds ([@B151]), Chick-fil-A ([@B46]), Subway ([@B203]), and Taco Bell ([@B207]) are slowly phasing in new commitments to greatly restrict antibiotic use in food production, largely in poultry.

Relevant Pathways for Antibiotics
---------------------------------

### Municipal and Industrial Wastewater

A large fraction of the antibiotics consumed by humans are excreted in the urine and feces in their biologically active form ([@B196]; [@B248]; [@B219]). The antibiotics excreted by humans will enter WWTPs, with one of three fates: (1) biodegradation ([@B44]); (2) absorption to sewage sludge ([@B138]; [@B3]); or (3) exit in the eﬄuent unchanged ([@B181]; [@B146]). Biologically active metabolites of the antibiotic which can be generated in the wastewater and in the wider environment are not being considered in this review, though they are potentially ecologically relevant ([@B93]).

The persistence of an antibiotic in a WWTP is a function of: (1) influent composition (industry, municipal) ([@B85]; [@B135]); (2) salinity; (3) temperature; (4) nature of WWTP (e.g., trickling bed filter, activated sludge, and membrane bioreactor); and (5) hydraulic retention time. A survey of 16 UK WWTPs revealed the presence of erythromycin, ofloxacin, and oxytetracycline (the only three for which they authors assayed) in each of the WWTPs ([@B85]). The median concentration of erythromycin was 2.0 μg/L ± 0.8 standard deviation \[(SD; 42% coefficient of variation (CoV)\]. The median concentration of ofloxacin had was 0.18 μg/L ± 0.33 SD (178% CoV), while oxytetracycline had a median concentration of 3.6 ± 2.5 SD (70% CoI) ([@B85]). The CoV for these antibiotics, ranged from 42 to 178% reinforcing the fact that sewage influent composition has a high degree of variability. The affinity of oxtetracycline to bind to sludge led to relatively high concentrations in the sludge as compared to other pharmaceuticals in the influent (1.15--43 mg/kg) ([@B85]). The preferential removal of some antibiotics \[e.g., sulfonamides ([@B243]), ciprofloxacin ([@B173])\] into the sludge suggests that the risks from sludge application to land are likely to be different from the risks from discharging sewage eﬄuent into rivers. The authors also reported enhanced removal of pharmaceuticals where there was iron dosing at the primary treatment stage of a trickling filter WWTP ([@B85]). Specifically, they reported an average loss of erythromycin, ofloxacin and oxytetracycline of 20, 74, and 51%, respectively, after iron-dosing (used to remove phosphorus), as compared to undosed primary treatment of -11, 19, and -4%, respectively. Concentrations of oxytetracycline within a river catchment receiving WWTP eﬄuent varied 14-fold across nine WWTP sampling days, from 9.4 to 137 g/d (normalized to flow) ([@B49]), illustrating the variability in antibiotic consumption and the extent to which environmental exposures to antibiotics can fluctuate.

### Greywater, Reclaimed and Black Water

The global water footprint in the period 1996--2005 was 9087 Gm^3^ year^-1^, of which 15% was categorized as gray water ([@B213]). Greywater is defined as water originating from the mains potable water supply that has been used for bathing or washing dishes or laundering clothes, excluding toilet water ([@B76]). Reclaimed water is typically water that originates from WWTP eﬄuent that has undergone additional treatment to ensure its safe use in a variety of applications, including irrigation and toilet flushing ([@B127]). Blackwater is recycled, treated sewage eﬄuent ([@B165]). The use of reclaimed water for irrigation purposes would be subject to Discharge Consent by the Environment Agency and would need to comply with British Standards (e.g., BS 8595:2013 Code of practice for the selection of water reuse systems; BS 8525-1:2010 and BS 8525-2:2011 Greywater systems. Domestic greywater treatment equipment. Requirements and test methods). While sewage wastewater in the U.S. must meet treatment guidelines set by individual states before used for irrigation, regulations do not require wastewaters originating from animal feeding lots to be treated before land application ([@B61]).

Although the use of reclaimed water is relatively new in the UK, it's a practice that is well-established in hot, dry climates where water pressures have been more acutely sustained ([@B98]). The prospect of less reliable water sources into the future, as a result of a changing climate, might make this source of water more important in the UK ([@B174]). Reclaimed water is currently used to sprinkler irrigate crops (e.g., lettuce, carrots, and green beans), golf courses, and landscapes ([@B127]; [@B35]; [@B209]), and as such is being introduced into soil habitats that might have previously been unexposed to significant quantities of ARGs or resistance-driving chemicals ([@B72]; [@B100]). The amplification of antibiotic resistant bacteria within distribution system for reclaimed water is poorly understood, but poses a potential risk to humans and the environment ([@B72]). Both treated sewage wastewater and animal feeding operations wastewater can have high levels of dissolved organic matter and nutrients as well as a highly variable microbial community activity and composition ([@B61]). The interaction between the microbial community, the antibiotics and the dissolved organic matter can greatly impact the fate of the antibiotics in the soil environment through a combination of biodegradation and adsorption ([@B61]).

### Veterinary and Livestock

As in humans, when animals consume antibiotics as much as 30 to 90% is released into the manure and urine ([@B189]; [@B20]). Animal excreta has been shown to contaminate the environment with antibiotic resistant bacteria and antibiotics ([@B212]; [@B233]). This phenomenon was recently demonstrated in a survey of feces from 20 commercial swine and 20 cattle farms in The Netherlands. The study reported antibiotics in 55% of the swine feces from 80% of the swine farms and 75% of the calf feces from 95% of the cattle farms ([@B20]). Among the antibiotics recovered, oxytetracycline, doxycycline, and sulfadiazine were the most frequent, followed by tetracycline, flumequine, lincomycin, and tylosin. Over one-third of the feces samples contained more than one antibiotic; as much as three different antibiotics in swine feces and eight different antibiotics in cattle feces. The authors concluded that the sum of the concentrations of different antibiotics within a sample exceeded concentrations needed to select for antibiotic resistance, e.g., the minimum selective concentration (MSC).

The observed transmission of resistance genes through contaminated cow and calf bedding and soil ([@B38]; [@B134]; [@B141]), highlights the importance of biosecurity and the need to separate animals being treated for infection from the herd (where feasible), and not reusing bedding from infected and treated animals ([@B154]). Intramuscular treatment of healthy calves with ceftiofur or florfenicol, as per manufacturer's recommendations, was shown to be sufficient to establish a reservoir of drug-resistant *Escherichia coli* in the feces, soil and bedding of treated animals ([@B141]). The dairy calves were housed individually in indoor pens with composted bedding material. Elevated levels of drug-resistant *E. coli* were maintained in the feces (collected directly from the rectum) and the bedding for a month. Treatment of the calves with oxytetracycline resulted in no significant effect--a result the authors attribute to the small trial size, but similar to a previous study comparing the differential effects of antibiotic administration route on antibiotic resistance generation in the microbiome ([@B247]). The authors also introduced a multi-drug resistant marked *E. co*li into the bedding of calves and found a significant increase in the *E. coli* population in the bedding of calves treated with ceftiofur as compared to the untreated control calves ([@B141]). Bedding-to-animal transmission was confirmed when calves were found to be shedding the multi-drug resistant marked *E. coli* in their feces. The authors also found co-selection of florfenicol-resistant *E. coli* after treatment of animals with ceftiofur and vice versa. This study exemplifies many of the factors that make control of AMR in a veterinary setting difficult: (1) persistence and shedding of the drug into the environment in urine and feces; (2) selection of antibiotic resistant organisms in the environment; and (3) transmission of drug-resistant microbes acquired from the environment ([@B141]).

The transmission of antibiotic resistant bacteria and genes from animals to humans has been demonstrated in the literature ([@B124]; [@B240]; [@B198]). On-farm transmission of AMR has been characterized in the literature for a wide range of animals: pigs ([@B51]; [@B160]), cows ([@B233]), and insects ([@B250]; [@B217]; [@B99]). A recent review of the academic literature that address the issue of antibiotic use in agriculture suggests that only seven studies (five percent) argued that there was no link between antibiotic consumption in animals and resistance in humans, while 100 (72%) found evidence of a link ([@B163]). The degree to which this transmission from animals to humans, and vice-versa, is of great interest and has significant implications for public and animal health ([@B231]; [@B237]; [@B128]). The relevance of theses pathways to the environment will be discussed, as this is the main remit and interest of environmental regulators.

### Land Application of Manure and Sludge

Biological treatment of wastewater generates sludge or 'biosolids,' a waste material of the WWTP that is high in undegraded protein, oils and fats as well as microorganisms and undegraded pharmaceuticals, the latter of which can reflect hundreds of different chemicals from sub-ng/L to \>10 μg/L ([@B75]; [@B150]). An estimated 37% of biosolids are land applied in Europe, equating to approximately 2.39 × 10^6^ dry tons per year ([@B126]). In 2008, approximately 1.4 million tons of dry sludge solids were produced in England and Wales, 77% of which was spread on land for agricultural benefit ([@B229]). Biosolids make up less than 5% of the total organic material going to agricultural land ([@B229]). All biosolids used on agricultural land in the UK are applied in accordance with The Sludge (Use in Agriculture) Regulations and The Code of Practice for the Agricultural Use of Sewage Sludge. The regulations are primarily concerned with the impact from metals contained in the sludge on the receiving soil and adjacent water bodies (ground and surface), however, they generically address any component of the sludge that negatively impacts the yield of crops or puts animal or human health at risk either directly or through the food chain ([@B56]).

The antibiotics that are more frequently found in sludge are those that are generally less water soluble, e.g., norfloxacin, ofloxacin, ciprofloxacin, trimethoprim, sulfamethoxazole, and doxycycline ([@B150]; [@B48]). The concentration of antibiotics within sludge and manure will vary greatly depending on the origin of the influent, treatment conditions, partitioning properties of the antibiotics, and environmental conditions ([@B107]; [@B45]; [@B139]). Two biocides, triclocarban and triclosan were the most abundant analytes in a large survey of pharmaceuticals and personal care products in sewage sludge in the U.S. They reached concentrations as high as: 48.1 and 19.7 mg kg^-1^ (dw), respectively, with mean concentrations of: 36 ± 8 and 12.6 ± 3.8 mg kg^-1^ (dw). The second most abundant class of chemicals was antibiotics, in order of decreasing concentration: ciprofloxacin \> ofloxacin \> 4-epitetracycline \> tetracycline \> minocycline \> doxycycline \> azithromycin, ranging between: 6.8 ± 2.3 and 0.8 ± 0.2 mg kg^-1^ dw ([@B150]). Notably, the biocides and antibiotics explored by [@B150] were typical of the small subset of antibiotic and biocides with a high affinity for sorption to sewage sludge ([@B138]).

Toxicological and AMR selection risks cannot be easily predicted from solely knowing the concentration of antibiotics, metals and biocides owing to significant uncertainties in bioavailability ([@B113]; [@B1]). Fluoroquinolones have been shown to be relatively biounavailable in some sludge amended soils, which was not correlated with any significant change to the ecosystem services: nitrification and denitrification; however, community structure and other ecosystem services might have been impacted, but were not examined ([@B183]). Similarly, soil fauna, such as earthworms, springtails, and enchytraeids exposed to environmentally relevant concentrations of antibiotics in soil showed no significant reduction in reproduction ([@B13]). Lowering of antibiotic, biocide and metal bioavailability in sludge will often decrease the exposure and the toxic response in mesofauna. Similarly, by lowering the bioavailability of these chemicals it is likely that the hazard to microorganisms will decrease, which might result in a reduction in the selective pressure ([@B113]; [@B61]). It remains undetermined the extent to which bioavailability controls resistance gene selection in the environment--an issue that emerges as a significant knowledge gap.

Ecological Relevance of Antibiotic Concentrations
=================================================

The well-established minimum inhibitory concentration (MIC) in clinical settings refers to the concentrations needed to inhibit the growth of, or kill, a target pathogen. The concentration at which a resistance genes offers a selective advantage to its 'host,' will be below the MIC, otherwise the microorganism would not survive. The MSC is a useful term that refers to the minimal concentration of chemical required to provide a selective advantage to a microorganisms carrying the resistance gene relative to the same bacterium that is sensitive to the chemical, i.e., not containing the resistance gene ([@B96]; [@B110]; [@B145]). The MSC is a theoretical threshold that can be carefully determined in the laboratory for any microorganism and chemical pair ([@B140]), but takes on a different meaning when applied to more realistic scenarios of multiple species and multiple chemicals. Efforts to determine MSCs for more complex systems are ongoing, and as a result of their more realistic conditions might offer greater insights into the ecological relevance of low concentrations of antibiotics in the environment ([@B245], [@B246]). The MSC has been shown to be sensitive to a range of biological and physico-chemical factors ([@B95]). Heterogeneity in the concentration of an antibiotic through differential partitioning into soil pores, sediment, biofilms, organic matter, are thought to play a significant role in allowing for the co-location of antibiotic resistant and sensitive microorganisms ([@B16]; [@B110]). Heterogeneity in the exposure of microorganisms to weakly selective sub-lethal concentrations of antibiotic within a matrix (e.g., soil, sediment, leaf, suspended particulate, and biofilms) allows for the selection and persistence of the more common, frequent small-effect mutations. The proximal location of microorganisms to higher or lower concentrations of these resistance-driving chemicals further aids in the establishment of these accumulated small mutations in the population ([@B110]; [@B41]).

Drivers of Resistance: Biocides
===============================

Biocides are disinfectants that are commonly used in hospitals, cosmetics, household cleaning products, wipes, and furniture preservatives, farmyards for purposes such as: wheel and foot washes and a range of industrial processes, including the control of fouling and souring of pipes including oil wells (e.g., hydraulic fracturing) ([@B119]). Some common biocides are: ethanol, formaldehyde, chlorhexidine, triclosan, and quaterium ammonium compounds \[QACs, e.g., BC also known as alkyldimethyl-benzyl-ammonium chloride (ADBAC), stearalkonium chloride, isothiazolium-benzalkonium chloride, cetrimonium chloride/bromide (cetrimide), cetylpyridinium chloride, alkyl amino alkyl glycines and didecyldimethylammonium chloride (DDAC)\] ([@B185]; [@B29]). In Europe, biocide marketing, use and disposal is regulated under the Biocidal Products Regulation (EU) 528/2012 ([@B69]). The legislation also controls their use in the veterinary setting. The global market for biocides grew by 40% between 1992 and 2007 ([@B190]).

The MIC for six different biocides has been shown to range from 0.4 to \>1000 mg/L across 16 different bacteria (e.g., *Pseudomonas aeruginosa, E. coli, Staphylococcus aureus, Citrobacter* sp.). Triclosan, along with other biocides, such as chlorhexidine and QACs, have been shown to select for antibiotic resistance ([@B67]; [@B26]; [@B40]; [@B230]; [@B30]). In much the same way that sub-lethal concentrations of antibiotic can select for ARGs, sub-lethal concentrations of biocides have also been shown to select for common mutations that confer clinically relevant antibiotic resistance ([@B230]). As previously discussed, some resistance mechanisms are common to both biocides and antibiotics, allowing for co-selection of ARGs ([@B149]; [@B137]; [@B185]). Co-resistance of *S. aureus* to the biocide benzalkonium chloride and the antibiotic oxacillin, affording the resistant strain eightfold higher tolerance to the antibiotic than its sensitive wild-type strain ([@B242]). The frequent co-location of these genes on plasmids (a small DNA molecule within bacteria that are physically separate from chromosomal DNA and can replicate independently) with ARGs affords them greater resilience and mobility, allowing for their rapid spread through microbial communities and pathogens ([@B86]; [@B167]).

The ecological relevance of biocides will need to be determined to effectively risk rank resistance-driving chemicals for mitigation--an issue that will be discussed in greater detail in following sections. The Scientific Committee on Emerging and Newly Identified Health Risks on behalf of the European Commission highlighted the potential consequences to the environment and human health from widespread biocide use in a recent report entitled "Assessment of the Antibiotic Resistance Effects of Biocides" where they call for: (1) a better understanding of the quantity of biocides and their residues in the environment and its effects on AMR selection; (2) methodologies for assessing impact on AMR; and (3) studies characterizing AMR and co-selection ([@B67]).

Relevant Pathways for Biocides
------------------------------

The route into the environment for biocides is similar to antibiotics, most notably WWTPs. Improper disposal of biocides through dilution and discharge to WWTPs can also increase the load of biocides entering the environment, while also increasing the likelihood of generating resistance.

Drivers of Resistance: Metals
=============================

Major urban inputs of heavy metals to WWTPs come from household eﬄuent, drainage water, business eﬄuent (e.g., car washes, dental uses, other enterprises), atmospheric deposition, and traffic-related emissions (vehicle exhaust, brake linings, tires, asphalt wear, gasoline/oil leakage) ([@B121]). Metal nanoparticles (e.g., titanium, copper, and silver) have become widely used in food, textiles, household, industrial and hospital products, and disinfectants ([@B193]). Metals such as Pb, Cu, Zn, Cd, and As have been used as animal growth promoters and nutritional supplements ([@B70]), fertilizers, pesticides, and fungicides in aquaculture and agriculture ([@B168]).

The annual heavy metal inputs to agricultural land in England and Wales for the year 2000 was substantially higher for livestock manures than for any other soil input ([@B158]). Sources of heavy metal input to agricultural soil, in decreasing mass (g/ha/yr), was: livestock manure (11,312), sludge (4,557), paper sludge (1,380), fertilizer \[89.7; including: nitrogen (2.2), phosphorus (34), potash (0.5), lime (53)\], atmosphere (221) and irrigation water (39) ([@B158]). The majority of heavy metals originating from animals can be found in the feed, with on average: 150--2920 mg Zn/kg dry matter and 18--217 mg Cu/kg dm in pig feeds--values of which depend on the age of the pigs ([@B157]). Poultry feeds contained a wider range, with: 28--4030 mg Zn/kg dm and 5--234 mg Cu/kg dm, again with variation in the age and breed of chicken ([@B157]). While concentrations of Zn and Cu in dairy and beef cattle feeds were much lower than in pig and poultry feeds. Dairy and beef cattle feed (dairy cake/nuts) contained 130--190 mg Zn (dm) and 35--40 mg Cu/kg (dm) ([@B157]). Supplements contained a mean of 2900 mg Zn/kg and 1500 mg Cu/kg (dm), while also containing higher levels of Ni, Pb, Cd, As, and Cr than other feed components ([@B157]).

Metal and antibiotic resistance can share structural and function resistance systems, such as: (1) reduced membrane permeability (metals: As, Cu, Zn, Mn, Co, Ag and antibiotics: ciprofloxacin, tetracycline, chloramphenicol and β-lactams); (2) drug and metal alteration (metals: As, Hg and antibiotics: β-lactams, chloramphenicol); (3) drug and metal eﬄux (metals: Cu, Co, Zn, Cd, Ni, As and antibiotics: tetracyclines, chloramphenicol, β-lactams); (4) alteration of cellular targets (metals: Hg, Zn, Cu and antibiotics: ciprofloxacin, β-lactams, trimethoprim, rifampicin); and (5) drug and metal sequestration (metals: Zn, Cd, Cu and antibiotics: coumermycin A) ([@B15]).

The toxicity of metals to microorganisms directly relates to the affinity of the metal to thiol compounds such as glutathione within the cell, in order of increasing 'toxicity'/S-affinity: Mn \< Co \< Zn \< Ni \< Cd \< Pb \<\< Cu \<\< Ag \< Hg ([@B159]). A log change in sulfur affinity brings a log decrease in the quantity of metal required to inhibit growth, i.e., increase in toxicity ([@B159]). This series of metals with increasing toxicity compares in an intriguing manner with a database of antibacterial biocide-and metal-resistance genes, BacMet ([@B168]). Of the 20 metal resistance genes for which there is experimental evidence of their function, copper genes are the most abundant, followed by, in decreasing order of their abundance in the database, with those metals that are non-essential for life in braces: Cu, Zn, Ni, (Cd), Co, Fe, Mn, (As), (Ag), (Te), (Hg), (Pb), Mn, (Cr), (Au), (Ga), (Sb), (V), Se, (Bi) ([@B168]). A rationale for this distribution will likely relate to a balance of fitness costs and benefits, which includes: (1) Discrepancies between the toxicity ranking and prevalence of metal-resistance genes in the BacMet database might be explained by: incomplete annotation of the function of some genes; non-exhaustive surveys of gene prevalence in the lab and environment; and non-uniform exposure and selection of metals and metal-resistance genes in the environment.

Considerable attention has been given to understanding the speciation of metals for predicting their mobility and toxicity in soils, sediment and aquatic system ([@B162]; [@B210]; [@B10]). However, it remains largely unexplored as to the relationship between metal bioavailability, speciation and resistance gene selection. The desire to limit resistance selection in soils might necessitate rethinking the environmental thresholds set for manure and sludge land spreading as the combined effects of antibiotics, biocides and metals might exceed the MSC for some shared resistance mechanisms.

Biological wastewater treatment processes have been shown to be disrupted as a result of the toxic effects of heavy metals in the influent ([@B90]; [@B197]), such as: nitrification ([@B24]), denitrification ([@B223]), and organics removal ([@B4]). The toxicity of heavy metals in wastewater is sensitive to the species and concentration of metal, pH, sludge concentration, wastewater pollution load and solubility of the metal ions, among other factors ([@B47]). Bacteria carrying metal resistance genes have been shown to more frequently carry ARGs as compared to those bacteria without metal resistance genes, and these genes can often be found on plasmids ([@B167]; [@B60]). It is common for a microbe to have both ARGs and metal resistance genes, however, a study of 4582 plasmids revealed that in only 5% of the cases are they both found on the same plasmid ([@B167]). It remains unclear whether the public database of plasmids from which this study was based offers a representative view of plasmid ecology; future targeted and controlled studies will help to support or challenge this important observation.

Relevant Pathways for Metals
----------------------------

Metals have similar pathways to that of biocides and antimicrobials, however, the relative proportion of each source is likely to differ depending on the prevalence of industry, agriculture (i.e., pesticides and biosolids), or waste water/stormwater. Rivers downstream of urban areas, where stormwater runoff is acute, and regions that have experienced mining, are often impacted with elevated concentrations of metals ([@B118]). It remains unclear as to the ecological relevance of these diffuse and point sources of metals to the selection for resistance in the environment.

Drivers of Resistance: Antibiotic Resistance Genes
==================================================

The chronic release of antibiotics into WWTPs is concomitant with the release of resistance genes. Resistance genes in wastewater originate from the gastrointestinal tract of, primarily, humans ([@B109]; [@B42]; [@B156]). The co-location of antibiotics and ARGs in WWTPs can (and does) select for novel combinations of AMR that can be shared between microorganisms by horizontal gene transfer (HGT) on mobile genetic elements (MGEs), such as plasmids, thereby increasing the prevalence and combination of multiple drug resistance in the microbial community ([@B206]; [@B241]). The competitive and chemically challenging environment of a sewage works offers favorable conditions for the amplification of existing resistance genes, creation of novel resistance genes or genomic assemblages ([@B249]).

Antibiotics can trigger the bacterial SOS response in which bacteria undergo a transient, genome-wide hypermutation that generates genetic variability in times of stress ([@B14]). The SOS response can also trigger HGT of ARGs, thereby providing a mechanism for the spread of ARGs from exposure to antibiotics ([@B19]). Many additional drivers (e.g., chemical and environmental) of HGT have been identified ([@B101]; [@B9]), including abiotic sources ([@B228]; [@B132]). The relative importance of each of these drivers of HGT has yet to be assessed at an ecologically relevant scale.

Resistance can be intrinsic, which suggests it is universally found within the genome of the bacterial species, while acquired resistance suggests it could be acquired by means of new genetic material or through sporadic mutations of intrinsic genes ([@B106]). Intrinsic resistance is maintained by a species independent of any antibiotic selective pressure and, by definition, is not acquired by HGT ([@B50]). Antibiotic-producing environmental microorganisms, unlike clinical microorganisms, demonstrate a significant degree of intrinsic resistance that appears to be independent of the selective pressure--an attribute that has been suggested to be ancient and long predates clinical antibiotic uses ([@B55]; [@B50]). The risk of intrinsic resistances found in environmental microorganisms being transferred to pathogens is already apparent and of significant international concern ([@B77]; [@B50]; [@B163]).

Intrinsic resistance can be further enhanced through the modification or enhancement of intrinsic resistance, e.g., upregulation of cellular components that protect against the effects of the antibiotic \[e.g., penicillin-binding protein 5 (PBP 5)\] ([@B194]), such modifications are then considered acquired resistance. A major mechanism for acquired resistance is through MGEs. MGEs can mobilize between cells through: (1) transformation, (2) conjugation and (3) transduction. Transformation is the acquisition of naked DNA from the environment ([@B54]; [@B87]). Conjugation is the transfer of genes through direct contact between two bacteria ([@B144]). Transduction is the transfer of genes from bacteriophage (viruses that infect bacteria) to bacteria during infection of a bacterial cell ([@B27]; [@B37]). MGEs can also be distinguished by their ability to freely transmit from cell to cell (i.e., intracellular MGEs) and those that can only transmit from cell to cell after integrating into intracellular MGEs ([@B195]). Intracellular MGE or transposable elements (TEs) include transposons (Tn), insertion sequences (ISs) and integrons (In) ([@B195]). Transposons are made up of conjugative transposons and integrative and conjugative elements (ICEs) ([@B239]). ICEs are genetic elements found in both Gram-positive and Gram-negative bacteria that are either self-transmissible or use mobile plasmids and viruses as vehicles for dissemination ([@B239]). The relevance of all these MGEs is that many contain 'cargo genes' that can confer phenotypes such as antibiotic resistance to the receiving cell ([@B182]; [@B116]). It is the numerous ways for resistance genes to mobilize and transfer from cell to cell that makes the environmental resistome of human and animal relevance ([@B171]). It goes beyond the scope of this review to further detail the many different mechanisms of MGE, a number of excellent papers cited above and here are recommended ([@B82]; [@B234]; [@B171]).

Relevance of AMR to Environmental Regulators?
=============================================

There are a large number of activities or products that are currently monitored or regulated by the Environment Agency of England, which intersect with the pathways and drivers of AMR (**Table [1](#T1){ref-type="table"}**). Equivalent legislation, if it exists, will differ by country, though many regulations are treated similarly across countries within the European Community with which England is aligned.

###### 

Environment and activities or products monitored or regulated by the Environment Agency of England, which play a potentially important role in the spread and maintenance of AMR in the environment.

  -------------------------------------------------------------------------------------------------------------------------------------------------------
  Environment                         Intersection of Environment Agency with AMR
  ----------------------------------- -------------------------------------------------------------------------------------------------------------------
  Wastewater treatment plant (WWTP)   ^1^Discharge of treated eﬄuent (from industry and municipal sewage) to land, coast or rivers.\
                                      ^1^Disposal of sewage sludge\
                                      ^1,2,3^Disposal of anaerobic digestate

  Agriculture                         ^1^Land spreading of manure, sewage sludge, and anaerobic digestate as fertilizer or soil conditioner.\
                                      ^1^Bioaerosols from agriculture (pig and poultry farming) and composting.

  Animal husbandry                    ^1^Disposal of animal by-products\
                                      ^1,2^Disposal of animal slurry and manure\
                                      ^1,2,3^Disposal of anaerobic digestate

  River water quality                 ^1,4^Impact of sewage eﬄuent\
                                      ^1,4^Impact of diffuse pollution from farm-yard, manure- and biosolid-amended agricultural soil and storm runoff\
                                      ^1,4^Freshwater fish farm

  Coastal and bathing waters          ^1,4^Impact of farmyard runoff and sewage eﬄuent on bathing water quality, and shellfish bed water quality\
                                      ^1,4^Impact of aquaculture on coastal water quality.

  Groundwater quality                 ^1,5^Leaching of soil amendments (biosolids and manure) and chemical crop treatments
  -------------------------------------------------------------------------------------------------------------------------------------------------------

Key regulations:

1

Environmental Permitting (England and Wales) Regulations 2010 (

Defra, 2013

);

2

Animal By-Products (Enforcement) (England) Regulations 2013 (

Public Health England, 2013

);

3

Anaerobic digestate: PAS 110:2014 (

BSI, 2014

);

4

Water Framework Directive 2000/60/EC (WFD) (

European Commission, 2000

);

5

The Sludge (Use in Agriculture) Regulations 1989 (

Public Health England and Wales, and Public Health Scotland, 1989

).

WWTP Discharge
--------------

Human use antibiotics, biocides, metals and ARGs all enter STPs, however, they are discharged as a component of the: (1) eﬄuent, and (2) sludge (biosolids). The sludge can be composted or anaerobically digested and applied to land or incinerated. The proportion of antibiotic, metal, and biocide in the eﬄuent and sludge is highly variable depending on the STP catchment characteristics, presence of hospital wastewater, nature of STP and its operational parameters. WWTPs do not efficiently remove all ARGs that are subsequently released in treated eﬄuents ([@B244]). So the key question is whether these ARGs contribute to the increased prevalence of ARGs in the environment and whether there are any ecological impacts from this chronic release?

Upon entering the river, estuary or coastal water, sewage eﬄuent will be diluted. The resulting concentration of pollutants (antibiotics, metals, biocides, and ARGs) will interact with the native flora and fauna and begin to change the microbial community structure and genetic makeup (e.g., prevalence of resistance genes). Changes in the microbial community by means of any number of mechanisms, of which pollution (e.g., metals, biocides, and antibiotics) is but one, have been shown to have significant impacts on the aboveground diversity and functioning of terrestrial ecosystems ([@B227]; [@B131]; [@B6]; [@B17]).

The introduction of these pollutants into recreational and coastal bathing water, primarily through combined sewer overflows (CSOs), will elevate exposures to humans ([@B136]) and by extension all wildlife that inhabits and feeds off/within the impacted water systems (e.g., shellfish or birds). However, little is known about the chronic effects from chemical exposure or the elevated prevalence of ARGs within a food web.

Land Spreading of Manure and Biosolids
--------------------------------------

Human and animal use antibiotics, biocides, metals, and ARGs can all be found within products, such as: sewage sludge, anaerobic digestate, manure or slurry, which are spread upon agricultural soil for the purpose of fertilizing crops and/or improving soil properties. The dissemination of these materials on soil increases the ARG exposure risk to: (1) (wild) animals; (2) crops; (3) adjacent surface water bodies; (4) groundwater; (5) farm workers; and (6) air as dust particles from land spreading or aeolian erosion ([@B104]; [@B74]; [@B134]). The persistence and changes in the 'resistome' \[the collection of genes that are capable of conferring resistance toward antibiotics when expressed in a susceptible organism ([@B53])\] of sludge or manure after it is anaerobically digested or composted is only recently emerging. A recent study demonstrated 156 unique ARGs and MGEs encoding resistance after composting sewage sludge, suggesting that the land spreading of composted sludge on a field will likely lead to the spread of ARGs in the soil and wider environment ([@B201]). An increase in the prevalence of key resistance genes in the bacterial and bacteriophage fraction after digestion of sludge led the authors to similarly conclude that the agricultural use of treated sludge could contribute significantly to the spread of ARGs in the environment ([@B36]). The persistence of antibiotics in soil varies greatly in the literature between a few days (chloramphenicol, ceftiofur) to as high as 300 days (oxytetracycline, sarafloxacin) ([@B208]). The persistence of antibiotics increases at low temperatures, unexposed to light (i.e., deeper soil layers), and often in high organic conditions, i.e., sludge or organic soils ([@B22]; [@B208]). The fate of many antibiotics in soil will also be sensitive to pH and soil properties ([@B133]).

The effects from land spreading of pig slurry on soil, as measured by increased prevalence of class 1 integrons (*intI1)*, has been shown to be maintained for several months after application ([@B32]). It has been suggested that the widespread use of land spreading of manure significantly contributes to the loading of some stretches of river and catchments, particularly in the U.S. where \>100 million tons of feces and urine was attributed to a 65 million-head of hog per year industry ([@B189]; [@B215]). The challenge of containing and disposing of feces is further impacted by substantial contributions from the cattle (95 million head of cattle in 2010) ([@B214]) and the poultry industries (8.5 trillion head of broiler chickens, 240 billion head of turkey) ([@B216]).

The dissemination of metals from within sludge/manure on soil has been shown to lead to measurable changes in microbial community structure and in some cases declines in ecosystem services, such as nitrification ([@B43]; [@B97]; [@B225]; [@B78]). However, there is no evidence that antibiotics are phytotoxic at concentrations found in sludge amended to soil ([@B114]). Determining whether antibiotics and ARGs have an impact on soil ecosystem health is a key area for environmental regulators, which does not fall within the scope of human health impacts.

Air Transmission (Bioaerosols)
------------------------------

Widespread manure distribution, either through feedlots or land spreading can facilitate the dissemination of ARGs ([@B11]; [@B152]; [@B226]). In addition, several antibiotics have been recorded downwind of feedlots at concentrations similar to that found in rivers downstream of sewage outlets (0.5 to 4.6 μg/g). More broadly, antimicrobials, such as antifungals (e.g., azole fungicides), have significant aerosol dissemination pathways. Broadcast application of azole fungicides has likely facilitated the emergence of azole-fungicide resistance in *Aspergillus fumigatus* (a life threatening infection of the lungs, and a common component of composting bioaerosols) ([@B221]). Strong evidence in support of an environmental origin of resistance can be found in the literature, where dominance of a single resistance mechanism in \>69% of Dutch azole-resistant *A. fumigatus* isolates was recovered from epidemiologically unrelated patients, indicating an environmental driver of resistance such as the use of azole fungicides for plant and material protection ([@B199]).

Food Plants
-----------

A significant number of papers exist in the literature demonstrating the sensitivity and uptake of antibiotics from irrigation water, manure- or sludge-amended soils by crops into the plant biomass ([@B120]; [@B12]). For example, onions, cabbage, and corn have been shown to take up chlortetracycline ([@B62]); corn, lettuce, and potato have been shown to take up sulfamethazine ([@B62]); wheat has been shown to take up chlortetracycline into the grain ([@B208]); lettuces and carrot were shown to take up trimethoprim ([@B23]). The degree to which this occurs in manure/sludge amended farms and the risk it poses to the environment remain poorly studied. The risk of phytoextracting antibiotics into a food products will be constrained by the mobility, bioavailability and persistence of antibiotics, which will be a function of the soil and its biological and physical properties. Only a small subset of all antibiotics in sludge and manure have been demonstrated to be phytoextracted into the plant biomass (e.g., sulfathiazole, sulfadiazine, sulfamethazine, sulfadimethoxine, chlortetracycline, and trimethoprim) ([@B208]). The risk and implications to herbivores (e.g., insect, livestock, and human) from exposure to elevated concentrations of antibiotic in plants has not been well documented.

Of those antibiotics that are able to be phytoextracted, some have been shown to phytoconcentrate ([@B63]). Those that phytoconcentrate can theoretically select for resistance in the microbiome of the plant as well as the organism that consumes/feed off the plant, despite apparently non-selective concentrations of antibiotics in the environment ([@B155]; [@B12]). A similar phenomenon has been shown for the phytoconcentration of metals, which cannot only theoretically impact the selection for metal resistance genes in the plant microbiome, but also in the herbivores that consume the plant ([@B235]). The phenomenon of bioaccumulation would need to be more explicitly understood if EQS's were to be developed for antibiotics, as concentrations within organisms might greatly exceed MSCs or effect concentrations, even if environmental concentration were maintained below an EQS.

The effect of chronic antibiotic exposure on aquatic plants has been poorly characterized, but there is evidence to suggest that antibiotic exposed aquatic plants demonstrate significant changes in the phyllosphere microflora --a change that has unknown ecological consequences ([@B180]).

Aquaculture and Shellfish Beds
------------------------------

Where there is veterinary use of antibiotics, biocides and/or metals in fish farms there will be increases in their environmental release, and concomitant selection for resistance genes. The accumulation and chronic exposure of river, estuarine and coastal environments to these AMR drivers can persist ([@B187]) and spread AMR into and from the sediment ([@B188]). The World Organization for Animal Health (OIE) has developed standards in the Aquatic Animal Health Code on the responsible and prudent use of antimicrobial agents in aquatic animals as well as a List of Antimicrobials of Veterinary Importance ([@B161]), which aims to optimize the balance between animal health needs and public health considerations. However, to date, there is no harmonized system of surveillance on the worldwide use and circulation of antimicrobial agents in aquaculture.

Antimicrobials are used in aquaculture to prevent and treat bacterial infections in fish and invertebrates ([@B34]), however, in middle to low income countries, it can often be used to overcome what is considered sanitary shortcomings in fish rearing ([@B33]). The UK reports the sale of 2 tons of antibiotics for use in the production of fish in 2014 ([@B222]). The 26 EU/EEA countries reported \<10% of the total weight of food-producing livestock was from fish, with the exclusion of Norway, for which it represented 70% ([@B71]). Canada, Norway and the U.S. permit aquaculture use of oxytetracycline, Canada and Norway permit use of florfenicol, and Norway permits aquaculture use of quinolones ([@B34]). The quantity of antibiotic used per country can vary by as much as 175-fold for 1 ton of salmon (e.g., 0.008--1.4 kg of antimicrobial) ([@B34]). The most abundant antibiotic (by mass) used in Norway for salmon production (821,997 MT in 2007), was a quinolone: oxolinic acid (681 kg in 2008), followed by florfenicol, a synthetic derivative of chloramphenicol (166 kg), and oxytetracycline (23 kg) ([@B31]). Scotland's salmon production (135,528 MT in 2007), by comparison, only used 9 kg florfenicol, and 75.4 kg of oxytetracycline in 2008 ([@B31]). Norway, the largest producer of farmed Atlantic salmon in the world, had up until the implementation of new regulations in 2007 used much higher antibiotics: 1119 kg oxolinic acid, 5282 kg oxytetracycline and 302 kg florfenicol, in 2006 ([@B31]).

The use and misuse of antibiotics in aquaculture has led to an increase in antibiotic resistance in fish pathogens, in the transfer of these resistance determinants to and from the sediment microbial community ([@B33]; [@B34]). Aquaculture has been shown to select for AMR in the fish microbiome and the surrounding environment ([@B58]; [@B94]; [@B192], [@B191]). Changes in the fish microbiome have unknown consequences, presenting a significant knowledge gap ([@B94]). The implications for the spread of AMR throughout the food web from fish-eating organisms has not been explored and is highlighted in the Knowledge Gap Section.

Groundwater Quality
-------------------

Antibiotics found in manure- or sludge-amended agricultural soils will enter groundwater as a result of rainfall, irrigation, and other human activities ([@B105]; [@B108]; [@B204]). A pan-European study of groundwater reported sulfonamide antibiotics in 24% of samples, reaching a maximum concentration of 38 ng/L, but averaging 2 ng/L ([@B143]). Among the higher concentrations of sulfonamides recorded in groundwater was from Spain, 3.4 μg/L ([@B84]). The biocides, i.e., triclosan, has been measured in UK aquifers in excess of 2 μg/L over a number of years ([@B200]; [@B148]). Groundwater infiltration of veterinary pharmaceuticals from livestock wastewater impoundments has also been demonstrated, highlighting the role of livestock wastewater lagoons in groundwater pollution ([@B18]). The implications for reduced groundwater depuration have been reported, where sulfamethazine and chlortetracycline was shown to inhibit the growth and denitrification of the nitrate present, thereby increasing the risk of nitrate pollution ([@B2]). Very little has been reported regarding the impact of antibiotic residues in groundwater on the generation of AMR in pathogens ([@B102]).

Ecological Health
-----------------

The toxicological response of organisms to exposure to antibiotic biocides and metals goes beyond the scope of this review. However, there are intriguing reports in the literature that document ecologically relevant effects on a range of target organisms from exposure to sub-lethal concentrations of pollutants, including antibiotics. Measurable changes in the metabolites found in feces of mice have been reported after exposure to sub-lethal concentrations of antibiotics. In a study on mice, the metabolites were found to be critical for host physiology (e.g., steroid hormone synthesis) and an inflammatory response in the gut ([@B142]). Chronic exposure of some organisms to metals have been shown to either increase or decrease an immune response and cause autoimmunity problems ([@B80]). The extent to which pollution-induced autoimmunity occurs in wildlife is unclear, however, where it does occur it is likely to have a measurable effect on the life-cycle and ecosystem services of that organism ([@B190]).

In the case of plants, there is evidence to suggest that seed germination, root elongation and overall plant health can be sensitive to sub-inhibitory concentrations of antibiotics and metals in the soil ([@B169]). Exposure to sub-lethal concentrations of pollutants such as antibiotics, biocides, and metals can induce pollution-induced parasitization, which in turn has been shown to increase susceptibility to the toxic effects of the pollutant ([@B123]). It is unclear how reproducible this linkage is between exposure and parasitization, but it has been suggested that parasites of aquatic organisms might potentially be used as indicators of pollution ([@B123]). This same relationship between pollution exposure (particularly metals) and increased susceptibility to infection has also been shown to occur in plants ([@B190]). There is the suggestion that pollution might have contributed to the observed increase in infections and abnormalities in amphibians, perhaps facilitated by host immune system effects or enhanced by persistent chemical pollutants acting in synergy or directly on the microbial pathogens to increase their persistence and virulence ([@B39]; [@B125]; [@B190]).

Bactericidal antibiotics, including β-lactams, quinolones, and aminoglycosides, can stimulate bacteria to produce reactive oxygen species (ROS), which are highly deleterious molecules that can interfere with the normal functions of oxygen-respiring organisms ([@B130]). ROS, such as hydroxyl radicals, are mutagens, which activates the error-prone SOS response and error-correcting repair systems. The induction of this DNA damage and repair cascade by low levels of antibiotics leads to an increase in mutation rates, which can result in the emergence of multidrug resistance ([@B130]). Hence, the mere presence of these radial oxygen species-inducing chemicals in the environment ensures that spontaneous mutations will occur at a greater rate and that antibiotic resistance can form *de novo* ([@B112]; [@B130]; [@B64]).

What are Our Key Knowledge Gaps?
================================

It has been noted that the wider problem of AMR has many parallels to that of climate change, as they are both, arguably, an interdisciplinary, complex, global "tragedy of the commons" ([@B79]; [@B236]; [@B237]). Many hundreds of researcher years have gone into producing our current understanding of the mechanisms of AMR selection and transmission ([@B8]). However, despite this deep knowledge base, we are still left unable to answer many rather fundamental questions about the ecology and drivers of AMR in the environment ([@B111]). Given the urgency of mitigating AMR, there is a need to prioritize our knowledge gaps into two categories: those that will inform policy and those that will not. A pragmatic view of research priorities is not novel, as funding bodies have 'Directed Research Calls' that often specify 'what we need to know.' However, the evidence suggests that these calls have been both limited in number (relative to the importance of the topic) and devoid of questions that pertain to environmental health. A recent report that conducted a systematic observational analysis of antibacterial resistance research funding, showed that only 3% of research projects on antibiotic resistance proposed to tackle issues that relate to the environment ([@B122]). One possible explanation for the dearth of research is that real world (field scale) environmental microbiology is messy and difficult to reproduce, and therefore seen less sympathetically by traditional grant review panels that tend to favor highly replicated and controlled studies --something rivers and WWTPs are not. A mechanism to prioritize the global research agenda on AMR and the environment does not yet exist; however, leadership from existing global bodies such as the WHO (World Health Organization), FAO (Food and Agriculture Organization) and OEI (World Organization for Animal Health) will be key, to ensure integration with existing global ([@B238]) and national ([@B59]) AMR Action Plans.

The following is a first attempt to shortlist the knowledge gaps that emerge from a review, with a focus on those which could directly inform policy.

1.  **Are there direct or indirect implications to the health, reproduction or ecosystem services of organisms or populations resulting from chronic exposure to elevated AMR drivers, as in **Figure [1](#F1){ref-type="fig"}**, in the environment?** Sub-question: (a) Can exposure to elevated AMR drivers increase susceptibility to infection, and how does this differ with age, gender, habitat quality, exposure time, mixture exposures?; (b) Are there implications to the environment from chronic exposure to elevated levels of ARGs and the MGEs in which they might be contained? (c) Do antibiotics, biocides or metals bioaccumulate and what are the implications for AMR selection, maintenance, and benchmarking regulatory thresholds?

2.  **What are the relative contributions of the different AMR [pathways]{.ul}, as in **Figure [1](#F1){ref-type="fig"}**, for establishing, maintaining and disseminating ARGs in the environment?** Sub-question: (a) Are there temporal, spatial, or physical/geological factors that impact on the selection, maintenance, and spread of AMR in the environment? (b) Should pathways be prioritized for mitigation based solely on potential impact, or should it include tractability (i.e., "easy win" vs. greater impact)?

3.  **What are the relative contributions of the different AMR [drivers]{.ul}, as in **Figure [1](#F1){ref-type="fig"}**, for establishing, maintaining and disseminating ARGs in the environment?** Sub-question: (a) How does ARG co-selection operate with mixtures of antibiotics, biocides and metals (e.g., concentration addition, independent action, synergism or antagonism)?; (b) Can understanding co-selection help define targets for mitigation--is this a tractable problem?; (c) Do bacteriophage play a meaningful role in the maintenance and transmission of ARGs in the environment? ([@B202]); (d) What are the sources of ARG-containing phage--is mitigation of phage tractable?

4.  **What concentrations of AMR drivers are relevant for assessing the risk of AMR selection and co-selection?** Sub-question: (a) What is a useful benchmark for assessing risk and the success of any mitigation/intervention measures (e.g., MIC, MSC, ARG prevalence, ecological cutoff/break points?); (b) What is the most appropriate time period for assessing the success of mitigating measures?

5.  **Are there direct or indirect implications from the trophic transfer of antibiotics, biocides, metals, or ARGs found within microorganisms, animals (aquaculture), or plants?** Sub-question: (a) Are some chemicals more susceptible to uptake (i.e., ionisable chemicals) in plants and do these pose the greatest risk to organisms and ecosystems?; (b) What are the effects of pH on the ionization of antibiotics and their differential toxicity to different target organisms?; (c) What role does metal speciation and metal bioavailability play in AMR selection and maintenance?; (d) How does antibiotic bioavailability in soil influence exposure and risk?

These knowledge gaps have been, in part, summarized in Eq. 1:
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where *R* \> 1 represents a high risk of ARG selection and *R* \< 1 represents a lower risk. An evidence-based determination (estimation) of the ARG-selection risk at each location can better inform and prioritize subsequent mitigation efforts.

Thought Experiment
==================

It has been widely shown that ARGs are a natural phenomenon, and that we have been living with ARGs in the environment (and within our microbiome), since the dawn of our species ([@B55]). It has been shown quite clearly in the literature, that there has been a substantial increase in the prevalence and diversity of ARGs since the time of mass production of antibiotics ([@B129]; [@B92]). So, is the problem with AMR in the environment simply a matter of increasing prevalence of ARGs? If it is a matter of prevalence, does prevalence of ARGs only have meaningful implications to humans and farmed animals? As previously discussed, there are numerous studies that show direct toxic or metabolic effects from exposure to the drivers of ARGs--this is not really debated. Whether these effects are meaningful to the population, community or ecosystem and its services is where our knowledge gap lies. Most studies focus on the organism; based on that sub-set of life on our planet, the answer is yes, there are measurable meaningful effects on many organisms to environmentally relevant concentrations of antibiotics, biocides and metals. However, it has been argued that some meaningful effects found at an organismal level might not translate into meaningful implications to the population, community, ecosystem and its services ([@B205]; [@B115]). There is a lack of research asking this "meaningful" level of impact at the appropriate scale--the ecosystem. The following four Thought Experiments, follow on with these critical questions, with the aim to highlight the obligate need for a critical interpretation of 'impact' and a pragmatic and holistic vision for mitigation where these are tractable, meaningful and efficacious.

Thought Experiment I
--------------------

The decision by the European Commission to include macrolides on the Watch List indicates that their environmental impact, based on classical toxicity studies, might be sufficiently high to justify their regulation. Will regulating macrolides contribute to a reduction in AMR? Where macrolides compose the majority of AMR drivers in a habitat, one might expect it could be impactful in reducing the prevalence of ARGs. However, there are few scenarios where this condition is met--possibly downstream a macrolide manufacturing facility. The reality is that most antibiotics enter the environment through sewage eﬄuent or from manure/biosolid-amended soil, all of which are rich in a wide range of AMR drivers (e.g., antibiotics, biocides and metals). Hence, it is unrealistic to expect macrolide regulation to substantially lower ARG selection. Establishing EQS's for macrolides should not be interpreted as a mitigation measure for AMR since there is no evidence to date to suggest these two goals are necessarily linked. Moreover, regulating macrolides will not eliminate their use, but simply lower their use and subsequent concentration the environment. The question remains whether a reduction in macrolide release into the environment to satisfy an EQS will reduce macrolide-ARG prevalence.

Thought Experiment II
---------------------

If the selection of ARGs within WWTPs is an important contributor of ARGs to the environment, then it might be of limited consequence that a WWTP employs technologies such as: activated carbon adsorption, advanced oxidation processes, nanofiltration, reverse osmosis, and membrane bioreactors ([@B146]), to target the removal of macrolides from its eﬄuent, as the ARGs have already been enriched within the treatment process and are being chronically released into the environment. There are no wastewater treatment technologies in widespread use that remove ARGs to zero. This scenario highlights an important knowledge gap: What is the relative importance of antibiotics, biocides, metals and ARGs for maintaining and disseminating ARGs in sewage works and the environment ([Knowledge Gap 3]{.ul})? If the release of ARGs into the river are deemed relatively unimportant, then there is more reason to suspect that the removal of metals, biocides or antibiotics could be useful. However, if metals are important relative to the other drivers, then treatment technologies will need to address this challenge. Technologies used to remove metals ([@B83]), such as chemical precipitation, ion-exchange, adsorption, membrane filtration, coagulation--flocculation, flotation and electrochemical are unlikely to be effective in reducing antibiotics, biocides or ARGs. Hence, defining the relative importance of resistance-driving chemicals to selection and dissemination of ARGs is key--as each will necessitate a different solution at the WWTP. In the case of ARGs, it will be important to discern the relative role of bacteriophage in the dissemination of ARGs, as they represent a nano-size particle that protects the ARGs held within it, making it very difficult to remove from the waste stream.

Thought Experiment III
----------------------

Emerging from Thought Experiments I and II is the idea that WWTPs are a major pathway for dissemination of AMR drivers. WWTPs are a convenient location for mitigating AMR and its drivers, as it represents the aggregation of many sources of resistance-driving chemicals and ARGs. However, addressing the AMR challenge at the point of the WWTPs comes with a very significant cost. It has been estimated that the UK water industry would require €30 billion in investment to comply with proposed EC limits on ethinyl estradiol (EE2, 'the pill') ([@B166]). Regulations on the release of macrolides in eﬄuent would likely garner a similar price tag. If solutions needed to be developed for substantially reducing levels of antibiotics, biocides, metals, and ARGs, it would greatly increase the cost of treating wastewater. Improvements in wastewater treatment to tackle the drivers of AMR can also offer reductions in a wide diversity of contaminants of emerging concern, including pathogens and viruses ([@B111]). As such, improvements to WWTPs might be more easily justified to the public in light of the broader benefits to society relative to the costs. In addition to upgrading WWTPs, there is reason to consider 'upstream' (i.e., close to source) mitigation measures (see Thought Experiment IV). It is also important to note that the UK water and sewerage industry is highly regulated to ensure the cost of bills is affordable. To that end, Ofwat (The Water Services Regulation Authority, the body responsible for economic regulation of the privatized water and sewerage industry in England and Wales) negotiates the research and investment budget with the water companies many years in advance. Work to develop the 2020--2025 business plans of all water and sewerage companies begins in 2016. Hence, there is a need to identify cheaper and quicker 'wins,' as the regulatory constraints on research and investment, the reluctance to exceed a maximum acceptable cost to the taxpayer, and the speed at which the industry is capable of responding are hugely limiting of any quick fixes.

Thought Experiment IV
---------------------

If the solution to mitigating AMR in the environment must move 'upstream' from the WWTP, it likely becomes the remit of several additional government regulators. AMR Action Plans might benefit from adapting the philosophy of the recycling movement "reduce, reuse, recycle" as it offers a more holistic and cost-effective mechanism for a reduction in the load of resistance-driving chemicals entering the waste stream. Without knowing the relative role of each of the drivers of AMR (antibiotics, biocides, metals, and ARGs), it would be necessary to identify, quantify and reduce each of the chemical drivers entering the wastewater. There are many activities currently underway on a global scale that aim to tackle some of these upstream sources of AMR drivers, e.g., reducing antibiotic misuse in human and veterinary use; reducing biocide use in personal care and household products; capture, reuse and recycle metals within the waste stream. The monumental task that this represents highlights the need to prioritize research to address these Knowledge Gaps.

Concluding Thoughts
===================

The relevance of the AMR pathways and drivers to the environmental regulator can be crudely summarized in three, high level, points:

1.  Low levels of antibiotics, metals, and biocides can directly select (and co-select) for ARGs within the AMR pathways that are under the remit of the Environment Agency, i.e., sewage eﬄuent, rivers, sludge, irrigation system, (bio)aerosols, aquaculture, industry, and groundwater.

2.  Pathways for the dissemination of antibiotics, metals, biocides, and ARGs into animals, plants, food (animal, plant and shellfish), groundwater, rivers and bathing waters, are within the remit of the Environment Agency.

3.  Sub-lethal effects of antibiotics, metals and biocides on organisms, their microbiome and ecosystem services (e.g., rivers, coastal waters, and soil) can impact the health, yield and safety of economically important food products and the wider biome.

It is clear that environmental regulators should have an important role to play in future efforts to mitigate the environmental and human health risks from AMR. However, it is also apparent, that they represent only one of many stakeholders that can contribute to the solution(s). Implementation of 'upstream' solutions, such as 'reduce, reuse, recycle,' will necessitate coordinated strategies across multiple regulatory bodies and stakeholders, including: *Department of Health* \[(including Medicines and Healthcare products Regulatory Agency, NHS England and Public Health England), Food Standards Agency\], *Department of Food, Agriculture and Rural Affairs* (Defra) \[including: Centre for Environment, Fisheries and Aquaculture Science, Water Services Regulation Authority (Ofwat)\], Veterinary Medicines Directorate, Environment Agency (equivalent regulator in adjacent countries: Scottish Environmental Protection Agency, Natural Resources Wales, Northern Ireland Environment Agency) as well as, Water and Sewerage Companies, industry and wider society. The first step toward this vision for a holistic AMR mitigation strategy, is for each of the stakeholders to critically evaluate the role they play in contributing to the composition and dissemination of resistance-driving chemicals. This document reflects a first effort to that end in England and the wider U.K.

It is important to recognize that the lack of environmental focus in AMR Action Plans and the O'Neill Review is, arguably, because: (1) our understanding of AMR in the environment is so unsatisfactory that there is very little that can be suggested for mitigation without employing the precautionary principle as the primary rationale for action, and (2) the disciplines of pollution, environmental microbiology, and the wider infectious disease fields have been chronically underfunded ([@B103]; [@B25]; [@B122]; [@B172]), leaving them unable to provide the evidence base needed to inform policy. Unless society is prepared to assume the non-trivial costs associated with a precautionary approach, e.g., increased water bills to pay for substantial upgrades in WWTPs, there will be a need to prioritize the research that addresses the 'Knowledge Gaps,' as previously detailed. The point should not be lost that such an investment in upgrading WWTPs might allow for multiple 'victories,' through the co-removal or reduction of other pollutants and hazards.

However, there is reason to be optimistic, as for the first time, all seven UK Research Councils have come together to collaborate on funding long-term cross-disciplinary, integrated research on AMR ([@B153]). An Antimicrobial Resistance Funders' Forum has also been established to provide a framework for delivering a more coordinated research portfolio and to maximize the impact on both a national and international policies and activities.
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